An additional chance of being cured
Clinicians throughout the world evaluate the efficiency of new cellular therapies and more than 5000 clinical studies are underway. As the initial results were particularly encouraging there is every indication that in the long-term:
- the number of diseases which will be treatable using haematopoietic and mesenchymal stem cells will increase:
- the cellular therapies will replace or supplement certain treatments applied routinely today;
- cellular therapies will make it possible to treat diseases which are still incurable today.
Application in regenerative medicine
Until now there have been hundreds of ongoing clinical trials which provide for the possibility of treatment of the following diseases:
Clinical trials with stem cells from umbilical cord blood
- Cerebral palsy
- Type 1 diabetes
- Respiratory stress pathologies in premature babies (anaemia),
- Autism
- Cardiological pathologies (hypoplastic left heart syndrome)
- Acquired hearing loss
- Genetic treatment for genetic pathologies
- Lymphoid leukaemia and multiple myeloma
- Anaemia
- Ischemic stroke
- Bone defects and problems in healing fractures
- Rheumatoid arthritis
- Multiple sclerosis
Clinical trials with stem cells from umbilical cord tissue
- Myocardium regeneration in the case of infarction
- Reconstruction of the damaged spinal cord following trauma
- Treatment of neurodegenerative diseases (Parkinson and Alzheimer’s disease)
- Treatment of skeletal muscle disorders
- Treatment of degenerative diseases of the liver, kidneys, retina, cornea, hearing
- Treatment of metabolic diseases (for example diabetes)
- Boney reconstruction
